RWD NeuroScience Animal Anesthesia System

Overview

The RWD NeuroScience Animal Anesthesia System is a fully integrated, CE-compliant platform engineered for precise, reproducible, and ethically sound anesthetic management in rodent and small mammal neuroscience research. Built upon a closed-circuit air/oxygen delivery architecture with calibrated vaporizer control, the system delivers consistent inhalational anesthesia using isoflurane or sevoflurane—two agents widely accepted under AAALAC International, NIH OLAW, and EU Directive 2010/63/EU guidelines for humane endpoints and surgical preparation. Its core design addresses three critical experimental requirements: (1) rapid and titratable induction/recovery kinetics (typically 2–5 minutes), (2) zero anesthetic gas leakage via hermetic seals and pressure-tested tubing pathways, and (3) real-time depth-of-anesthesia modulation through digital vaporizer output (0.1–5.0% vol/vol range, ±0.05% accuracy). The system integrates seamlessly with stereotaxic frames—including RWD’s full line of digital, motorized, and multi-animal compatible platforms—enabling simultaneous neurosurgical procedures on up to five rodents without cross-contamination or flow interference.

Key Features

• Triple-stage waste-gas scavenging system compliant with ISO 8573-1 Class 2 compressed air purity standards and OSHA PEL (Permissible Exposure Limit) thresholds for halogenated anesthetics
• Dual-mode vaporizer options: Pour-fill, Easy-fill, and Key-fill configurations supporting both isoflurane and sevoflurane; compatible with Cagemont and Selectatec mounting interfaces
• Induction chamber with rapid oxygen flush (<9 seconds clearance time) and integrated CO₂ monitoring port for metabolic validation
• Modular animal interface kit: Interchangeable nose cones, bite bars, ear bars, and paw restraints validated for mice (15–30 g), rats (200–500 g), guinea pigs (300–800 g), rabbits (1–3 kg), and cats (≤7 kg)
• Fail-safe pressure regulation: Dual redundant solenoid valves and upstream pressure sensors ensure stable flow across 0.2–2.0 L/min range, even during transient occlusion events
• Electromechanical interlock between vaporizer activation and gas flow initiation—prevents accidental agent delivery without carrier gas

Sample Compatibility & Compliance

The system supports longitudinal and acute neurophysiological paradigms requiring stable physiological baselines, including but not limited to: stereotaxic implantation of intracranial cannulae, microdialysis probe insertion, chronic electrode array placement, optogenetic fiber optic coupling, and intraoperative electrophysiological recording (LFP, single-unit, EEG). All components meet IEC 61000-4 electromagnetic compatibility standards and are certified for use in GLP-compliant facilities. Waste-gas capture efficiency exceeds 99.7% per ANSI Z79.11-2022 specifications. Documentation packages include full traceability of calibration certificates (NIST-traceable flow meters), material biocompatibility reports (ISO 10993-5 cytotoxicity testing), and conformity declarations for RoHS 2011/65/EU and REACH Annex XVII restrictions.

Software & Data Management

While the base ANE-100 series operates via analog control panel with tactile feedback dials and LED status indicators, optional RWD NeuroLink™ digital module enables USB-C connectivity to Windows-based acquisition workstations. This module logs timestamped vaporizer output, O₂ flow rate, chamber temperature, and ambient pressure at 1 Hz resolution—exportable as CSV or HDF5 for integration into LabChart, Spike2, or custom Python/MATLAB analysis pipelines. Audit trails comply with FDA 21 CFR Part 11 requirements when paired with RWD’s validated eLogbook software, supporting electronic signatures, role-based access control, and immutable record retention for regulatory submissions.

Applications

• Establishment of translational models: Parkinson’s disease (6-OHDA lesion), Alzheimer’s disease (APP/PS1 transgenic surgery), spinal cord injury (hemisection + grafting), and traumatic brain injury (controlled cortical impact)
• In vivo neuropharmacology: Intracerebroventricular (ICV) or intraparenchymal drug infusion via chronically implanted cannulae under stable surgical plane
• Functional neuroimaging support: Synchronized anesthesia maintenance during fMRI, intrinsic optical signal imaging (IOSI), or laser speckle contrast angiography (LSCI)
• Chronic electrophysiology: Multi-day tetrode or silicon probe recordings with minimal post-operative stress artifact
• Wireless telemetry integration: Coordinated use with DSI TA-F10 or Ponemah platforms for concurrent cardiovascular and neural activity monitoring

FAQ

Is the system compatible with non-RWD stereotaxic frames?
Yes—the gas delivery manifold features standardized 1/8″ NPT and Swagelok®-compatible ports, enabling integration with David Kopf, Stoelting, and Leica Biosystems frames via optional adapter kits.
Can the vaporizer be calibrated in-house?
Calibration requires RWD-certified service technicians using NIST-traceable anesthetic gas analyzers; field recalibration is not supported due to ISO 80601-2-13 medical device safety requirements.
What documentation is provided for IACUC protocol submission?
RWD supplies a complete technical dossier including risk assessment (ISO 14971), gas pathway schematics, material declarations, and third-party test reports for inhalational agent stability and residual toxicity.
Does the system support dual-agent switching (e.g., isoflurane → sevoflurane) during a single procedure?
No—vaporizers are agent-specific and physically sealed; switching requires hardware replacement and recalibration per ISO 80601-2-13 Annex BB.
Are consumables such as CO₂ absorbent cartridges supplied by RWD?
Yes—RWD offers SorbSafe™ granular soda lime (8–12 mesh, 95% Ca(OH)₂) in 1.5 kg vacuum-sealed packs, certified for ≥12 hours continuous use at 1.0 L/min flow.